Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue:
Total revenue	$ 117,665	$ 56,567
Operating expenses:
Cost of revenue	1,584	2,207
Research, development and other related costs	29,139	27,039
Selling, general and administrative	37,803	30,569
Amortization expense	22,509	25,459
Litigation expense	2,103	1,290
Total operating expenses	93,138	86,564
Operating income (loss)	24,527	(29,997)
Interest expense	(4,251)	(6,685)
Other income and expense, net	565	2,302
Income (loss) before taxes	20,841	(34,380)
Provision for (benefit from) income taxes	2,056	(8,950)
Net income (loss)	18,785	(25,430)
Less: net loss attributable to noncontrolling interest	(551)	(347)
Net income (loss) attributable to Xperi	$ 19,336	$ (25,083)
Income (loss) per share attributable to Xperi:
Basic	$ 0.39	$ (0.51)
Diluted	$ 0.39	$ (0.51)
Weighted average number of shares used in per share calculations-basic	49,945	48,721
Weighted average number of shares used in per share calculations-diluted	50,199	48,721
Royalty and License Fees
Revenue:
Total revenue	$ 117,665	$ 56,567